(Reuters) - Kaisa Group Holdings Ltd said on Wednesday it planned to buy a 2.19 billion yuan ($332 million) stake in blood products producer Zhenxing Biopharmaceutical & Chemical Co Ltd as the Chinese developer diversifies and expands its footprint in the healthcare industry. Shenzhen China Health , a unit of the group , is to acquire a 18.57 % stake worth CNY2.19bn ( $ 332 m ) in blood products maker , Biopharmaceutical & Healthcare , as it looks to expand in other sectors along with its presence in the health care industry .
Shenzhen China Health , a unit of the group , is to acquire a 18.57 % stake worth CNY2.19bn ( $ 332 m ) in blood products maker , Biopharmaceutical & Healthcare , as it looks to expand in other sectors along with its presence in the health care industry .